The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.
Rapid Market Expansion
- Market Growth: The platelet aggregation devices market has seen significant growth, increasing from $0.67 billion in 2023 to $0.83 billion in 2024 at a CAGR of 25.3%.
- Historic Drivers: This growth is driven by the increasing prevalence of cardiovascular diseases, rising incidences of bleeding disorders, growing awareness about health diagnostics, and a surge in surgical procedures.
Future Market Projections
- Forecasted Growth: The market size is projected to reach $2.07 billion by 2028, growing at a CAGR of 25.5%.
- Future Drivers: Contributing factors include a growing aging population, rising demand for point-of-care testing, expansion of personalized medicine, regulatory support, and increasing prevalence of chronic diseases.
- Key Trends:
- Integration of artificial intelligence in diagnostics.
- Development of portable platelet aggregation devices.
- Increased collaboration between biotech firms and healthcare providers.
- Rising importance of data analytics in healthcare.
- Shift towards home-based diagnostics.
View More On The Platelet Aggregation Devices Market Report 2024 – https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report
Increasing Incidence of Target Diseases
Impact on Market Growth
- Target Diseases: Focused on cancer, cardiovascular diseases, and diabetes, these conditions significantly impact public health.
- Role of Devices: Platelet aggregation devices aid in early detection and management of thrombotic risks, preventing complications like heart attacks and strokes.
- Statistics: The International Agency for Research on Cancer (IARC) reported 20 million new cancer cases in 2022, with projections indicating a rise to over 35 million by 2050.
Major Players in the Market
Key Companies
- Notable Firms: Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG & Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Drucker Diagnostics, Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago.
Innovations in Platelet Aggregation Devices
Technological Advancements
- Platelet Pooling Set: In February 2023, TERUMO BCT INC. launched the IMUGARD WB Platelet Pooling Set, approved by the FDA. This set offers extended shelf life for platelets and supports improved supply management.
- Product Features: The device enables platelet recoupment from whole blood donations and has FDA clearance for seven-day storage, addressing the need for enhanced platelet availability.
Strategic Acquisitions
Enhancing Market Portfolio
- Cell Microsystems Acquisition: In August 2023, Cell Microsystems acquired Fluxion Biosciences Inc. This acquisition expanded their product portfolio with IonFlux, BioFlux, and IsoFlux systems.
- Technological Integration: The acquisition integrated automated patch clamp technology for advanced cellular electrophysiology and innovative tools for live cell assays and comprehensive platelet aggregation studies.
Market Segmentation
Detailed Breakdown
- By Product: Reagents, Systems, Consumables, and Accessories.
- By Type: Four Channel, Dual Channel, Eight Channel.
- By Technology: Optical, Impedance, Other Technologies.
- By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Orthopedic Applications, Other Applications.
- By End-User: Standalone Hospitals, Diagnostic Laboratories, Research and Academic Institutes, and Other End Users.
Regional Insights
- Largest Region: North America dominated the market in 2023.
- Fastest-Growing Region: Asia-Pacific is expected to lead in growth during the forecast period.
Request A Sample Of The Global Platelet Aggregation Devices Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15896&type=smp